Skip to main content
. 2019 Jul-Sep;63(3):249–256.

Table 3.

Comparison of question specific analysis of OSDI in the Polyquad travoprost and BAK-preserved travoprost group

OSDI Questionnaire Polyquad group BAK group
Q1 - Q5 (Symptoms) 6.3 +/ - 2.62 14.8 +/ - 6.57
Q6 - Q9 (Functional limitation) 2.2 +/ - 0.73 5.6 +/ - 2.76
Q10 - Q12 (environmental factors affecting the ocular surface) 3.9 +/ - 1.73 8.69 +/ - 4.12